Your browser doesn't support javascript.
loading
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
van Barele, Mark; Akdeniz, Delal; Heemskerk-Gerritsen, Bernadette A M; Andrieu, Nadine; Noguès, Catherine; van Asperen, Christi J; Wevers, Marijke; Ausems, Margreet G E M; de Bock, Geertruida H; Dommering, Charlotte J; Gómez-García, Encarnacion B; van Leeuwen, Flora E; Mooij, Thea M; Easton, Douglas F; Antoniou, Antonis C; Evans, D Gareth; Izatt, Louise; Tischkowitz, Marc; Frost, Debra; Brewer, Carole; Olah, Edit; Simard, Jacques; Singer, Christian F; Thomassen, Mads; Kast, Karin; Rhiem, Kerstin; Engel, Christoph; de la Hoya, Miguel; Foretová, Lenka; Jakubowska, Anna; Jager, Agnes; Sattler, Margriet G A; Schmidt, Marjanka K; Hooning, Maartje J.
Affiliation
  • van Barele M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Akdeniz D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Andrieu N; INSERM, U900, Paris, France.
  • Noguès C; Institut Curie, Paris, France.
  • van Asperen CJ; Mines ParisTech, Fontainebleau, France.
  • Wevers M; Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France.
  • Ausems MGEM; Institut Paoli-Calmettes & Aix Marseille University, INSERM, IRD, SESSTIM, Marseille, France.
  • Dommering CJ; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
  • Gómez-García EB; Department for Clinical Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • van Leeuwen FE; Division of Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Mooij TM; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Easton DF; Department of Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Antoniou AC; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Evans DG; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Tischkowitz M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Frost D; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Brewer C; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Olah E; The Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Simard J; Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
  • Singer CF; Manchester Breast Centre, Oglesby Cancer Research Centre, The Christie, University of Manchester, Manchester, UK.
  • Thomassen M; Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Kast K; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
  • Rhiem K; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada.
  • Engel C; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • de la Hoya M; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, UK.
  • Foretová L; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
  • Jakubowska A; Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, Quebec City, QC, Canada.
  • Jager A; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Sattler MGA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
  • Schmidt MK; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Hooning MJ; Centre for Personalized Response Monitoring in Oncology (PREMIO), Odense University Hospital, Odense, Denmark.
J Natl Cancer Inst ; 115(11): 1318-1328, 2023 11 08.
Article in En | MEDLINE | ID: mdl-37369040
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Países Bajos